Company Registration No. 09414326 (England and Wales)
PHARMACARE4U LTD
Unaudited accounts
for the year ended 31 August 2025
PHARMACARE4U LTD
Unaudited accounts
Contents
PHARMACARE4U LTD
Company Information
for the year ended 31 August 2025
Directors
JAGDEEP KLER
JUTINDER KAUR KLER
Company Number
09414326 (England and Wales)
Registered Office
63 WEST ROAD
NEWCASTLE UPON TYNE
NE4 9PX
Accountants
Miah & Co Chartered Certified Accountants
Beda House
Clough Dene
Stanley
Co Durham
DH9 9PN
PHARMACARE4U LTD
Statement of financial position
as at 31 August 2025
Tangible assets
256,537
161,728
Cash at bank and in hand
1,485,997
1,331,811
Creditors: amounts falling due within one year
(389,007)
(397,815)
Net current assets
1,177,754
1,004,636
Net assets
1,434,291
1,166,364
Called up share capital
2
2
Profit and loss account
1,434,289
1,166,362
Shareholders' funds
1,434,291
1,166,364
For the year ending 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 25 May 2026 and were signed on its behalf by
JUTINDER KAUR KLER
Director
Company Registration No. 09414326
PHARMACARE4U LTD
Notes to the Accounts
for the year ended 31 August 2025
PHARMACARE4U LTD is a private company, limited by shares, registered in England and Wales, registration number 09414326. The registered office is 63 WEST ROAD, NEWCASTLE UPON TYNE, NE4 9PX.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Turnover represents the value, net of VAT and discounts, of goods provided to customers and work carried out in respect of services provided to customers.
Tangible fixed assets policy
Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Intangible fixed assets (including purchased goodwill and patents) are included at cost less accumulated amortisation.
4
Intangible fixed assets
Goodwill
At 1 September 2024
400,000
At 1 September 2024
400,000
PHARMACARE4U LTD
Notes to the Accounts
for the year ended 31 August 2025
5
Tangible fixed assets
Plant & machinery
At 1 September 2024
323,249
At 1 September 2024
161,521
Charge for the year
64,135
Amounts falling due within one year
Trade debtors
55,986
49,572
7
Creditors: amounts falling due within one year
2025
2024
Trade creditors
198,728
185,841
Taxes and social security
91,039
93,703
Proposed dividends
100,000
100,000
Other creditors
16,260
37,475
Allotted, called up and fully paid:
2 Ordinary shares of £1 each
2
2
9
Average number of employees
During the year the average number of employees was 23 (2024: 19).